Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records

Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records

Introduction 4.2 million individuals in the UK have type 2 diabetes, a known risk factor for dementia and mild cognitive impairment (MCI). Diabetes treatment may modify this association, but existing evidence is conflicting. We therefore aimed to assess the association between metformin therapy and...

Full description

Bibliographic Details
Main Authors: Liam Smeeth, Nish Chaturvedi, Carol Brayne, Rohini Mathur, Krishnan Bhaskaran, Rutendo Muzambi, Charlotte Warren-Gash, Christopher T Rentsch, Dylan M Williams, Susanna J Dunachie, William Doran, Louis Tunnicliffe, Sophie V Eastwood
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/12/1/e003548.full

Internet

https://drc.bmj.com/content/12/1/e003548.full

Similar Items